About: TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis (en) TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis (nl)
skos:prefLabel	TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis (en) TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis (nl)
name	TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis (en) TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis (nl)
title	wds:Q66039745-288A04E0-B450-4B0C-AB1F-85913BF2DBCE
title	TBTC Study 22: Efficacy and Safety of Once-Weekly Rifapentine and Isoniazid Compared to Efficacy and Safety of Once-Weekly Rifapentine and Isoniazid Compared to Twice-Weekly Rifampin and Isoniazid in the Continuation Phase of Therapy for Pulmonary Tuberculosis (en)
instance of	wds:Q66039745-3868021B-6B96-49DE-85ED-9B4554168811
instance of	clinical trial
start time	wds:Q66039745-F4AD17D8-BA4F-44D7-A5F8-57BEE819E444
start time	1995-04-01 00:00:00Z (xsd:dateTime)
country	wds:Q66039745-4D37B81B-FF7E-4D94-B3B8-F33E0564E2D3 wds:Q66039745-CAFBA8BF-2C1A-458D-A76C-AC01CA603A53
country	Malawi United States of America
research site	wds:Q66039745-50492FA9-964D-4093-A029-D3D8BCB02F45 wds:Q66039745-8B2A6C09-AE10-476E-9A92-A36D7EA56330 wds:Q66039745-A7B60326-F5E7-4582-8132-B21A1B586E8E wds:Q66039745-A9DE462A-8FDE-475C-A36C-028AD2D119EA wds:Q66039745-AF48E797-7033-4F69-B557-110D74727224 wds:Q66039745-B31064C1-C67B-4C76-A72E-85E0BB7CB5B1 wds:Q66039745-D5222213-6E22-4D22-8B04-788A58D75A86 wds:Q66039745-DF8E2772-3A0C-45A5-8BE5-E1653EAB310C wds:Q66039745-FC89E32C-BC43-4B7A-9914-188D2653DB7C
research site	Carolinas Medical Center Boston University University of California, San Francisco New York University University of Manitoba University of British Columbia Vancouver campus New Jersey Medical School University of North Texas Health Science Center Duke University Medical Center
research intervention	wds:Q66039745-35F2EA33-A87F-435A-B78D-101866ED058E wds:Q66039745-B8A3D0D7-3B52-4C16-9A48-7E4DBC673115
research intervention	rifampicin rifapentine
minimum age	wds:Q66039745-1C7D3ED1-4E68-4D60-9A61-0D85119E792C
minimum age	18 (xsd:decimal)
medical condition	wds:Q66039745-2C3B9720-81E7-4C85-9B89-036823CD93E6
medical condition	tuberculosis
number of participants	wds:Q66039745-8E3BE110-541A-4712-AD7A-A025CF05645F
number of participants	1000 (xsd:decimal)
study type	wds:Q66039745-708F9F99-CDF0-4EB8-B07A-0C6F5C245B8E
study type	interventional study
ClinicalTrials.gov ID	wds:Q66039745-9BFCA86D-8EB8-493E-B437-E0076CEACBB2
ClinicalTrials.gov ID	NCT00023335
clinical trial phase	wds:Q66039745-022CC54F-C5A1-4910-BEC6-09EB91FFF062
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66039745

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software